Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccine
Dendritic/tumor-fusion vaccine provides good clinical responses
May 10th, 2006
Cancer immunotherapy using a dendritic/tumor-fusion vaccine induces elevation of serum anti-nuclear antibody with good clinical responses. "Dendritic cell (DC) vaccines might induce both anti-tumor immunity and autoimmunity. In this report, we demonstrate elevated levels of anti-nuclear antibody (ANA) in the sera of patients with cancer who had received immunotherapy with a dendritic/tumor-fusion vaccine," stated investigators in Japan. "Twenty-two patients were treated with DC vaccine of fusion cells composed of autologous DCs and tumor cells (DC/tumor-fusion vaccine), which was generated by treating each cell type with polyethylene glycol," said...
Source: Vaccine Weekly (2006-05-10)
|
